If you are not happy with the results, please do another search

JSA advises Coforge on its 100% acquisition of Rythmos

JSA represented Coforge in its acquisition of a 100% stake in Rythmos Inc. from its stockholders for an aggregate deal value of approximately INR 424 crores.

The team assisted in all aspects of the transaction, including structuring, negotiating and finalising the definitive agreements. Rythmos is engaged in the IT/ITes industry and provides cutting edge services with data and cloud services primarily in the USA and India.

Our transaction team comprised: Lead Partner – Anand Lakra, Partner – Niharika Mepani, Senior Associate – Jinay Shah, and  Associates – Diya Dave, Rahi Barfiwala, Ishan Saxena, and Garima Agarwal.

Our employment team comprised: Partner – Sonakshi Das and Associate – Muskan Jain.

Our data privacy team comprised: Associates – Maitrayi Jain, Sherin Jose, and Sankalp Inuganti.

JSA advised ASG Hospital on its acquisition of Vission Eye Hospital

JSA advised ASG Hospital on its acquisition of Vission Eye Hospital, set up by Dr. Himanshu Mehta, a leading ophthalmologist.

Our transaction team comprised: Lead Partner – Siddharth Mody, Partner – Rohan Kumar, and Senior Associate – Alister Sequeira.

Our due diligence team comprised: Principal Associate – Prerana Chaudhari, Senior Associate – Alister Sequeira, and Associate – Ayush Chaturvedi.

JSA advised GD Foods on its proposed sale to Adani Wilmar

JSA advised GD Foods and its promoter on the proposed sale of the company to Adani Wilmar Limited. The sale is subject to customary closing conditions.

GD Foods-owned ‘Tops’ brand is among the top three players in the tomato ketchup and pickles category.

Our transaction team comprised: Lead Partner – Siddharth Mody, Partner – Rohan Kumar, Senior Associate – Yamini Upadhyay, and Associate – Ayush Chaturvedi.

JSA advises Promoters of Mega Fine Pharma Private Limited on acquisition of majority stake by Motilal Oswal

JSA advised Mr. Shailesh Sanghvi (Promoter and Managing Director) and other continuing Promoter shareholders of the Sanghvi family in relation to a transaction involving acquisition of majority stake of Mega Fine by MO Alternate Investment Advisors Private Limited, a subsidiary of Motilal Oswal Financial Services Limited. Shailesh Sanghvi and family will continue as Promoters of Mega Fine.

Mega Fine is a Mumbai based export focused company engaged in development, manufacturing, and sale of a diverse range of high-value, low-volume niche for chronic therapies active pharmaceutical ingredients (APl). It has two USFDA approved manufacturing facilities in Nashik and Vapi. Mega Fine has long-standing relations with leading global pharmaceutical companies and has achieved global market leadership in some of its key APls.

Our transaction team comprised: Lead Partner – Vikram Raghani, Partner – Abhijeet Sonawane, and Associates – Vaishnavi Vyas and Tanishqua Desai.

Investment in JQR Sports (India) Private Limited

JSA advised JQR Sports (India) Private Limited in connection with the investment by Venturi (a Singapore based private equity fund) to subscribe to shares of JQR Sports (India) Private Limited for an aggregate consideration of USD 25,000,000. The investment is proposed to be undertaken in two tranches, and the first tranche investment by Venturi has been completed.

Our transaction team comprised: Lead Partner – Sidharrth Shankar, Partner – Nandini Seth, Principal Associate – Aditya Vardhan Dayal, Senior Associate – Rupaly Middha, and Associate – Eksha Narayan.